Itron (ITRI) Slammed After Losing BGE Contract, But Deutsche Bank Sees No Major Impact and Says "Buy"
ITRI Hot Sheet
Rating Summary:9 Buy, 9 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 11 | New: 38
Shares of Itron, Inc. (Nasdaq: ITRI) are under heavy pressure today after Maryland's Public Service Commission revealed that BG&E is working with Silver Spring Networks for its smart metering platform, not Itron.
Commenting on the news, analyst at Deutsche Bank said, "If BG&E gets regulatory approval (next
hearings on 8/5/10 and 8/6/10) and partners with SSN (not a certainty at this point, but very likely), there would not be any impact to our 2010 or 2011 EPS estimates for Itron."
Deutsche Bank thought that Itron only had a 30% chance of winning this contract. If they had won it would have added $0.15-0.20 of upside to the firm's 2011 EPS estimate.
While they remained concerned about Itron's limited AMI pipeline and recent share loss, they are reiterating our Buy rating as we see significant upside to the Street's 2010 estimates and opportunities
in the EU market.
Shares of Itron are down 7.2 percent today to $60.39.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Commenting on the news, analyst at Deutsche Bank said, "If BG&E gets regulatory approval (next
hearings on 8/5/10 and 8/6/10) and partners with SSN (not a certainty at this point, but very likely), there would not be any impact to our 2010 or 2011 EPS estimates for Itron."
Deutsche Bank thought that Itron only had a 30% chance of winning this contract. If they had won it would have added $0.15-0.20 of upside to the firm's 2011 EPS estimate.
While they remained concerned about Itron's limited AMI pipeline and recent share loss, they are reiterating our Buy rating as we see significant upside to the Street's 2010 estimates and opportunities
in the EU market.
Shares of Itron are down 7.2 percent today to $60.39.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Biosante Pharma (BPAX) Volatility Elevated on Trader Profit Taking
- Goldman Sachs Boosts Target on Williams-Sonoma (WSM) On Signs of Stabilization
- Renren (RENN) Volatility Rises Amid Facebook Weakness; Shares Break Below Key Levels
Create E-mail Alert Related Categories
Analyst Comments, Momentum Movers, Trader TalkRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
